Clinical Trials: Lipid Regulating Agents
- Acipimox 12 studies
- Allicin 5 studies
- Amlodipine, atorvastatin drug combination 15 studies
- Anticholesteremic Agents 1266 studies
- Atorvastatin 491 studies
- Benfluorex 1 study
- Betaine 22 studies
- Bezafibrate 5 studies
- Chitosan 19 studies
- Cholestyramine Resin 10 studies
- Choline 73 studies
- Ciprofibrate 2 studies
- Clofibrate 2 studies
- Clofibric Acid 16 studies
- Colesevelam 35 studies
- Colestipol 4 studies
- Dalcetrapib 12 studies
- Efamol 10 studies
- Essential 303 forte 1 study
- Ethionamide 1 study
- Ezetimibe 201 studies
- Fenofibrate 125 studies
- Fenofibric acid 26 studies
- Fluvastatin 51 studies
- Gemfibrozil 14 studies
- Glucuronyl glucosamine glycan sulfate 15 studies
- Hydroxymethylglutaryl-CoA Reductase Inhibitors 1250 studies
- Hypolipidemic Agents 1639 studies
- Isoniazid 85 studies
- Lovastatin 45 studies
- Niacin 205 studies
- Pitavastatin 42 studies
- Policosanol 13 studies
- Polyene phosphatidylcholine 2 studies
- Pravastatin 107 studies
- Probucol 16 studies
- Red yeast rice 18 studies
- Rice bran oil 1 study
- Rosuvastatin 233 studies
- Simvastatin 373 studies
- Sitosterol 4 studies
- Sucrose polyester 3 studies
- Torcetrapib 15 studies
- Triclosan 43 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_Lipd
